Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocol
Article in Surgical Oncology Insight (June 2024)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis
Article in Med (March 2024)
Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes
Article in Cancers (April 2023)